Evidence gap on antihyperglycemic pharmacotherapy in frail older adults
Bollig, C.; Torbahn, G.; Bauer, J.; Brefka, S.; Dallmeier, D.; Denkinger, M.; Eidam, A.; Klöppel, S.; Zeyfang, A.; Voigt-Radloff, S. · Zeitschrift für Gerontologie und Geriatrie · 2020 · Heft 4 · S. 278 bis 284
Bibliografische Angaben
Zusammenfassung
IntroductionSince 1980 the global prevalence of diabetes mellitus (DM) has nearly doubled up to 422 million people worldwide in 2014 and is estimated to redouble in the next 20 years [44]. In high-income countries, DM prevalence was 3 times higher among 65–69 year old patients compared to low income countries and peaked in the 75–79 years age group (22%) [6]. Late complications of DM, such as myocardial infarction, stroke, renal failure, peripheral arterial occlusive disease, diabetic retinopathy and polyneuropathies, negatively impact the quality of life and daily functioning of patients, and represent major co…
